Home / Announcements / President Trump to Nominate ViraCyte’s Brett Giroir as HHS Assistant Secretary for Health

President Trump to Nominate ViraCyte’s Brett Giroir as HHS Assistant Secretary for Health

Brett Giroir

President Donald Trump plans to nominate Brett Giroir, president and CEO of biopharmaceutical company ViraCyte, as assistant secretary for health at the Department of Health and Human Services.

The White House said Friday that Giroir previously held the roles of executive vice president and CEO at the Texas A&M Health Science Center and as director of the defense science office at the Defense Advanced Research Projects Agency.

He also worked as chief medical officer at Children’s Health in Dallas, CEO of Health Science and Biosecurity Partners, managing director at Kirchner Group, strategic adviser at TMCx Accelerator and a partner at TransBio Ventures.

Giroir serves as a scientific advisory board member at the MD Anderson Cancer Center’s Cancer Moonshots Program and A. Alfred Taubman Medical Research Institute at the University of Michigan as well as chair of the Veterans Choice Act Blue Ribbon Panel to Review and Assess the Veterans Health System.

He also teaches pediatrics, tropical medicine and medical ethics and health policy at Baylor College of Medicine in Houston.

This story was originally published on April 25, 2017.

Check Also

Four Universities to Manage Nuclear Research Centers Under DOE NNSA Partnerships

The Department of Energy's National Nuclear Security Administration has selected four universities to operate new centers of excellence under a shared allotment of $40.5M. These new centers will work to foster collaboration between the NNSA and academia under the Stewardship Science Academic Alliances program, the DOE said Monday.

Leave a Reply

Your email address will not be published. Required fields are marked *